Does cigarette smoking affect the diagnostic reliability of hemoglobin alpha2delta2 (HbA(2))?
Quantitation of hemoglobin alpha2delta2 (HbA(2)) is a basic and confirmatory test in diagnosing the carrier state of beta-thalassemia. The present study was designed to investigate the effect of cigarette smoking on the diagnostic reliability of HbA(2). A total of 2,867 (654 smokers […]
Surgical staging and cervical cancer: after 30 years, have we reached a conclusion?
Moore DH.
Gynecologic Oncology of Indiana, Indianapolis, Indiana.
Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit.
BACKGROUND.: Predictors of outcome and rates of successful discharge have not been defined for patients with acute leukemia admitted to intensive care units (ICUs) in the US. METHODS.: This is a retrospective analysis of 90 patients with […]
Erratum.
Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
BACKGROUND.: It has been postulated that radiation induces breast cancers in atomic bomb (A-bomb) survivors. Oncogene amplification is an important mechanism during breast carcinogenesis and also serves as an indicator of genomic […]
Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
BACKGROUND.: Maintenance of telomeres has been identified as an essential regulator of proliferative capacity and genomic integrity in malignant tumors. The authors evaluated telomere length and telomerase subunits, hTR and hTERT, as prognostic markers in patients with Barrett carcinoma. METHODS.: […]
Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection.
BACKGROUND.: Esophageal cancer is an aggressive cancer with a reported 3-year survival of 20%. However, early-stage esophageal cancer can be cured by endoscopic resection (ER). The long-term survival of esophageal mucosal squamous cell carcinoma after ER was investigated by […]
Reply to Valproic Acid for the Treatment of Myeloid Malignancies.
Kuendgen A, Gattermann N, Krieger O.
Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine University, Dusseldorf, Germany.
Valproic acid for the treatment of myeloid malignancies.
Shah P, Mato A, Luger SM.
Leukemia Program, Division of Hematologyâ€Oncology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
BACKGROUND.: Ovarian cancer patients frequently receive chemotherapy near the end of life. The purpose of the current study was to develop indicators that characterize those ovarian cancer patients who have a short life span. METHODS.: The medical charts of deceased […]
